Humana (NYSE:HUM) Updates FY 2024 Earnings Guidance

Humana (NYSE:HUM - Get Free Report) issued an update on its FY 2024 earnings guidance on Thursday morning. The company provided earnings per share (EPS) guidance of 16.000- for the period, compared to the consensus estimate of 16.150. The company issued revenue guidance of -.

Wall Street Analysts Forecast Growth

Several brokerages have issued reports on HUM. Royal Bank of Canada cut their price objective on Humana from $400.00 to $265.00 and set an "outperform" rating on the stock in a research note on Tuesday, October 8th. Deutsche Bank Aktiengesellschaft decreased their price target on shares of Humana from $349.00 to $250.00 and set a "hold" rating for the company in a report on Thursday, October 3rd. JPMorgan Chase & Co. boosted their price objective on Humana from $332.00 to $396.00 and gave the company a "neutral" rating in a research report on Wednesday, August 21st. Truist Financial dropped their target price on Humana from $400.00 to $260.00 and set a "hold" rating on the stock in a research report on Friday, October 11th. Finally, Stephens reiterated an "equal weight" rating and issued a $250.00 price objective on shares of Humana in a research report on Wednesday, October 9th. Twenty equities research analysts have rated the stock with a hold rating and six have issued a buy rating to the company's stock. Based on data from MarketBeat, the stock currently has an average rating of "Hold" and a consensus target price of $300.50.

Humana Price Performance

Shares of NYSE HUM traded down $4.07 during mid-day trading on Thursday, reaching $235.78. The company had a trading volume of 2,424,284 shares, compared to its average volume of 1,868,266. Humana has a 1-year low of $213.31 and a 1-year high of $475.00. The stock has a market cap of $28.39 billion, a PE ratio of 20.88, a P/E/G ratio of 2.15 and a beta of 0.53. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.67. The company has a 50-day moving average price of $274.32 and a two-hundred day moving average price of $322.31.

Humana (NYSE:HUM - Get Free Report) last released its earnings results on Wednesday, October 30th. The insurance provider reported $4.16 earnings per share for the quarter, topping the consensus estimate of $3.48 by $0.68. Humana had a net margin of 1.18% and a return on equity of 13.20%. The business had revenue of $29.30 billion for the quarter, compared to the consensus estimate of $28.66 billion. On average, equities analysts anticipate that Humana will post 16.14 earnings per share for the current year.

Humana Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, January 31st. Shareholders of record on Tuesday, December 31st will be paid a $0.885 dividend. The ex-dividend date of this dividend is Tuesday, December 31st. This represents a $3.54 annualized dividend and a yield of 1.50%. Humana's dividend payout ratio is presently 31.36%.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.